Vaccine Chatbot for Improving Influenza Vaccination Uptake

Launched by FUDAN UNIVERSITY · Oct 23, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether an AI-powered chatbot can help more families get their young children vaccinated against the flu. The trial will focus on children aged 6 to 59 months who haven't received a flu vaccine in the last two flu seasons. Parents of these children will be invited to participate if they are visiting clinics and can provide informed consent. The chatbot will answer any questions parents have about the flu vaccine, aiming to improve their understanding and confidence in getting their children vaccinated.

During the study, families will be divided into two groups: one group will use the chatbot for a month and a half, while the other group will not have access to it. The researchers will compare how many children in each group get vaccinated, as well as how much parents learn about the vaccine and how confident they feel about it. This trial is not yet recruiting participants, but it aims to find out if using a chatbot could make a difference in flu vaccination rates among young children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Parents of the child visiting clinics.
• • Children aged between 6 and 59 months.
• • Children who have not received an influenza vaccine in both the current and previous flu seasons and have not yet made an appointment for an influenza vaccine.
• • Children who have no contraindications to receiving an influenza vaccine.
• • Provide informed consent and willing to participate throughout the study.
• Exclusion Criteria:
• • Children vaccinated or appointed for influenza vaccination or with any contraindication to influenza vaccine.
• • Parents with mental disorders or visual/reading impairments, and unable to cooperate with and undergo the intervention activities.
• • Unwilling to participate.